Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
for Hidradenitis Suppurativa (HS)
Drug: Povorcitinib
108 locations incl. Birmingham
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT06855498·Phase 3·Recruiting